A Phase 3, Randomized, Observer Blinded Study to Evaluate the Safety and Immunogenicity of Two Booster Doses of the NVX-CoV2515 Vaccine in Adults Previously Vaccinated with Other COVID-19 Vaccines

  • Jenkin, Grant (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/05/22 → 30/04/23

Keywords

  • phase 3 study
  • vaccine safety
  • Immunogenicity
  • vaccine efficacy
  • COVID-19

Clinical Trial Phase

  • Phase III (a & b)